Clinical trials, research, drug trials

The drugmaker said it would delay new study starts and also enrollments in ongoing studies due to the strain the pandemic is putting on clinical trial sites. However, patients already enrolled in trials can continue treatment. Bristol-Myers Squibb said it would continue to assess trial operations.

LEAVE A REPLY

Please enter your comment!
Please enter your name here